Greetings!

It is a distinct pleasure to introduce our new name and logo!

This exciting new look and feel is transformative. It represents a transition from our beginnings with indoor allergens to a multi-faceted company with interests and expertise in protein expression, biomanufacturing, molecular diagnostics, and environmental testing. We are truly “InBio”: One company with facilities in the US and the UK.

InBio’s authentic scientific expertise enable diagnostic and therapeutic allergy products to be developed. InBio provides the research you need to advance products and diagnostic systems, seize business opportunities and overcome real-world challenges: Research Made Real.

The timing of this rebranding comes as no coincidence, as InBio celebrates 25 years in allergy in the US!

InBio will be launching our new look at the American Academy of Allergy, Asthma and immunology meeting in Phoenix, AZ, Feb 25-28. Throughout the year, we will be rolling out new product designs and imaging, including a redesigned website, and other initiatives.

InBio will be presenting our latest research on food allergy, human IgE monoclonal antibodies, gene editing of Fel d 1 and a T cell test for SARS-CoV-2 at the AAAAI.

Please visit our exhibit at Booth 1018 to learn more and meet our scientific team.

We look forward to catching up!

Best regards,
Martin D. Chapman, PhD
President and CEO